Published in Cancer Weekly, December 13th, 2005
The research entitled, Dual Targeting of the Tumor Vasculature: Combining Avastin with CA4P or OXi4503, were presented by Dietmar Siemann, PhD, from the Department of Radiation Oncology, Shands Cancer Center, University of Florida,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.